Amgen Inc v. Pharmascience Inc
Amgen Inc v. Pharmascience Inc is a federal patent - anda lawsuit filed on 07/11/2018 in the District Court, D. New Jersey. The case was terminated on 06/11/2021.
A lawsuit records allegations and procedural activity. Being named as a party does not establish liability, wrongdoing, or the merits of any claim.
- Court
- District Court, D. New Jersey (D.N.J.)
Official Court Website → - Assigned judge
- Michael A. Shipp · 5,509 cases in index
- Docket number
- 3:18-cv-11545
- Cause
- 15:1126 Patent Infringement
15 U.S.C. § 1126 - Nature of suit
- 835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application. - Jurisdiction
- Federal Question
- Jury demand
- None
- Date filed
- 07/11/2018
- Date terminated
- 06/11/2021
629 Patent - ANDA cases in this court are indexed here.
Parties
- plaintiff · Amgen Inc Pharmaceuticals & Biotechnology · 229 cases
- defendant · Pharmascience Inc · 6 cases
Other Cases Naming This Defendant
PHARMASCIENCE INC is named in 6 federal civil cases in this index. Recent Patent - ANDA cases naming the same defendant:
About Patent - ANDA Lawsuits
ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.
Frequently Asked Questions
What is Amgen Inc v. Pharmascience Inc?
Amgen Inc v. Pharmascience Inc is a federal patent - anda lawsuit filed on 07/11/2018 in the District Court, D. New Jersey. The case was terminated on 06/11/2021. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.
What type of case is this?
It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.
What court is the case in?
The case is in the District Court, D. New Jersey, docket number 3:18-cv-11545.
When was the case filed?
Amgen Inc v. Pharmascience Inc was filed on 07/11/2018. It was terminated on 06/11/2021.
What law is the case brought under?
The docket lists the cause as 15 U.S.C. § 1126.
Other Cases Involving These Parties
Related Patent - ANDA Cases
Source: public U.S. federal court record — docket 7412692 in the CourtListener/RECAP archive (verify this docket), court docket number 3:18-cv-11545 on PACER. Court, party, date and judge fields are reproduced from that record; case-type categories, statute decoding and all aggregate figures are derived by Docket Nexus (methodology).